диссертации / 85
.pdf111
Belyavskaya, L. Tonelli, E.M. Sternberg // Int Immunol. – 2007. – Vol. 19. - № 3. – P.
287-96.
40.Chakravarty, D. Estrogen receptor beta (ERbeta) in endometrial simple hyperplasia and endometrioid carcinoma / D. Chakravarty, R. Srinivasan, S. Ghosh, A. Rajwanshi, S. Gopalan // Appl Immunohistochem Mol Morphol. – 2008. – Vol. 16. - №
6.– P. 535-42.
41.Chang, C.P. Non-genomic rapid inhibition of Na+/H+-exchange 1 and apoptotic immunosuppression in human T cells by glucocorticoids / C.P. Chang, S.W. Wang, Z.L. Huang, O.Y. Wang, M.I. Huang, L.M. Lu, D.C. Tarng, C.H. Chien, E.J. Chien // J Cell Physiol. – 2010. – Vol. 223. - № 3. – P. 679-86.
42.Chen, Y. Mifepristone increases the cytotoxicity of uterine natural killer cells by acting as a glucocorticoid antagonist via ERK activation / Y. Chen, Y. Wang, Y. Zhuang, F. Zhou, L. Huang // PLoS One. – 2012. – Vol. 7. - № 5. – P. 36413.
43.Collins, F. Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha / F. Collins, S. MacPherson, P. Brown, V. Bombail, A.R. Williams, R.A. Anderson, H.N. Jabbour, P.T. Saunders // BMC Cancer.
–2009. – Vol. 9. – P. 330.
44.De Carvalho, S. Differential expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women / S. de Carvalho, A.B. Campaner, S.M. Lima, M.A. Silva, P.A. Ribeiro // Anal Quant Cytol Histol. – 2011. – Vol. 33. - № 2. – P. 61-7.
45.Druckmann, R. Progesterone and the immunology of pregnancy / R. Druckmann, M.A. Druckmann // J Steroid Biochem Mol Biol. – 2005. – Vol. 97. -№ 5.
–P. 389-96.
46.Ehring, G.R. A nongenomic mechanism for progesterone-mediated immunosuppression: inhibition of K+ channels, Ca2+ signaling, and gene expression in T lymphocytes / G.R. Ehring, H.H. Kerschbaum, C. Eder, A.L. Neben, C.M. Fanger, R.M. Khoury, P.A. Negulescu, M.D. Cahalan // J Exp Med. – 1998. – Vol. 188. - № 9. –
P. 1593-602.
112
47.Engmann, L. Progesterone regulation of human granulosa/luteal cell viability by an RU486-independent mechanism / L. Engmann, R. Losel, M. Wehling, J.J. Peluso // J Clin Endocrinol Metab. – 2006. – Vol. 91. - № 12. – P. 4962-8.
48.Enninga, E.A. Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma / E.A. Enninga, S.G. Holtan, D.J. Creedon, R.S. Dronca, W.K. Nevala, S. Ognjanovic, S.N. Markovic // Mayo Clin Proc. – 2014. – Vol. 89. - № 4. – P. 520-35.
49.Falkenstein, E. Multiple actions of steroid hormones-a focus on rapid, nongenomic effects / E. Falkenstein, H.C. Tillmann, M. Christ, M. Feuring, M Wehling // Pharmacol Rev. - 2000. – Vol. 52. - № 4. – P. 513-56.
50.Giangrande, P.H. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding / P.H. Giangrande, E.A. Kimbrel, D.P. Edwards, D.P. McDonnell // Mol Cell Biol. –
2000. – Vol. 20. - № 9. – P. 3102-15.
51.Gul, A. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and its relationship to clinical parameters / A. Gul, M. Ugur, C. Iskender, E. Zulfikaroglu, G. Ozaksit // Arch Gynecol Obstet. -2010. – Vol.
281.- № 3. – P. 479-83.
52.Howlader, N. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations) [Электронный ресурс] / N. Howlader, A.M. Noone, M. Krapcho, N. Neyman, R. Aminou, W. Waldron, S.F. Altekruse, C.L. Kosary, J. Ruhl, Z. Tatalovich, H. Cho, A. Mariotto, M.P. Eisner, D.R. Lewis, H.S. Chen, E.J. Feuer, K.A. Cronin // National Cancer Institute. Bethesda, MD. – 2012. – Режим доступа:
http://seer.cancer.gov/csr/1975_2009_pops09/.
53.Hughes, G.C. Progesterone and Autoimmune Disease / G.C. Hughes // Autoimmun Rev. – 2012. - Vol. 11. - № 6-7. – P. 502–514.
54.Hughes, G.C. The intracellular progesterone receptor regulates CD4+ T cells and T cell-dependent antibody responses / G.C. Hughes, E.A. Clark, A.H. Wong // J Leukoc Biol. – 2013. – Vol. 93. - № 3. – P. 369-75.
113
55.Ibrahim-Quali M. Recent advances in oxasteroid chemistry / M. IbrahimQuali // Steroids. – 2007. Vol. 72. - № 6-7. – P. 475-508.
56.Inceboz, U.S. Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps / U.S. Inceboz, N. Nese, Y. Uyar, H.T. Ozcakir, O. Kurtul, Y.B. Baytur, A.R. Kandiloglu, H. Caglar, I.S. Fraser // Gynecol Obstet Invest. –
2006. – Vol. 61. - № 1. – P. 24-8.
57.Iwai, K. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma / K. Iwai, K. Fukuda, T. Hachisuga, M. Mori, M. Uchiyama, T. Iwasaka, H. Sugimori // Gynecol Oncol. – 1999. – Vol. 72. - № 3. – P. 351-9.
58.Jarboe, E.A. Endometrial intraepithelial neoplasia / E.A. Jarboe, G.L. Mutter // Semin Diagn Pathol. – 2010. – Vol. 27. - № 4. – P. 215-25.
59.Jazaeri, A.A. Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression / A.A. Jazaeri, K.J. Nunes, M.S. Dalton, M. Xu, M.A. Shupnik, L.W. Rice // Oncogene. – 2001. – Vol. 20. - № 47. – P. 6965-9.
60.Jeon, Y.T. Steroid receptor expressions in endometrial cancer: clinical significance and epidemiological implication / Y.T. Jeon, I.A. Park, Y.B. Kim, J.W. Kim, N.H. Park, S.B. Kang, H.P. Lee, Y.S. Song // Cancer Lett. – 2006. – Vol. 239. - №
2.- P. 198-204.
61.Jones, L.A. Differential modulation of TLR3and TLR4-mediated dendritic cell maturation and function by progesterone / L.A. Jones, S. Kreem, M. Shweash, A. Paul, J. Alexander, C.W. Roberts // J Immunol. – 2010. - Vol. 185. - № 8.
– P. 4525-34.
62.Jongen, V. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer / V. Jongen, J. Briët, R. de Jong, K. ten Hoor, M. Boezen, A. van der Zee, H. Nijman, H. Hollema // Gynecol Oncol. – 2009. – Vol. 112. - № 3. – P. 537-42.
63.Kamat, A.A. EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer / A.A. Kamat, D. Coffey,
114
W.M. Merritt, E. Nugent, D. Urbauer, Y.G. Lin, C. Edwards, R. Broaddus, R.L. Coleman, A.K. Sood // Cancer. – 2009. –Vol. 115. - № 12. – P. 2684-92.
64.Kidd, P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease / P. Kidd // Altern Med Rev. – 2003. – Vol. 8. - № 3.
–P. 223-46.
65.Kowalik, M.K. The putative roles of nuclear and membrane-bound progesterone receptors in the female reproductive tract / M.K. Kowalik, R. Rekawiecki, J. Kotwica // Reprod Biol. – 2013. – Vol. 13. - № 4. – P. 279-89.
66.Kudela, M. Prognostic importance of selected molecular immunohistochemical markers and DNA ploidy in endometrial cancer / M. Kudela, R. Pilka, M. Lubusky, P. Hejtmanek, P. Dzubak, S. Brychtova // Eur J Gynaecol Oncol. –
2012. – Vol. 33. - № 2. – P. 159-63.
67. Lopes, R.G. Analysis of estrogenand progesterone-receptor expression in endometrial polyps / R.G. Lopes, E.C. Baracat, L.C. de Albuquerque Neto, J.F. Ramos, S. Yatabe, D.B. Depesr, U.G.Lippi // J. Minim Invasive Gynecol. – 2007. – Vol. 14. - № 3. – P. 300-3.
68.Lusher, S.J. X-ray structures of progesterone receptor ligand binding
domain in its agonist state reveal differing mechanisms for mixed profiles of 11βsubstituted steroids / S.J. Lusher, H.C. Raaijmakers, D. Vu-Pham, B. Kazemier, R. Bosch, R. McGuire, R. Azevedo, H. Hamersma, K. Dechering, A. Oubrie, M. van Duin,
J.de Vlieg // J Biol Chem. – 2012. – Vol. 287. - № 24. – P. 20333-43.
69.Lysenko, O.N. Immunohistochemical study of the expression of receptors to steroid hormones in endometrial hyperplastic processes / O.N. Lysenko, M. Kh. Ashkhab, N.V. Strizhova, I.I. Babichenko // Arkh Patol. – 2004. – Vol. 66. - № 2. –
P.7-10.
70.Maeda, Y. Effect of progesterone on Th1/Th2/Th17 and regulatory T cell-related genes in peripheral blood mononuclear cells during pregnancy in cows / Y. Maeda, H. Ohtsuka, M. Tomioka, M. Oikawa // Vet Res Commun. – 2013. – Vol. 37. -
№ 1. – P.43-9.
115
71.Mariani, A. HER-2/neu overexpression and hormone dependency in endometrial cancer: analysis of cohort and review of literature / A. Mariani, T.J. Sebo, J.A. Katzmann, D.L. Riehle, S.C. Dowdy, G.L. Keeney, T.G. Lesnick, K.C. Podratz // Anticancer Res. – 2005. – Vol. 25. - № 4. – P. 2921-7.
72.Markova, I. Selected immunohistochemical prognostic factors in
endometrial cancer / I. Markova, M. Duskova, M. Lubusky, M. Kudela, J. Zapletalová,
M.Procházka, R. Pilka // Int J Gynecol Cancer. – 2010. – Vol. 20. - № 4. – P. 576-82.
73.Matsuzaki, J. Immunosteroid as a regulator for Th1/Th2 balance: its possible role in autoimmune diseases / J. Matsuzaki, T. Tsuji, I. Imazeki, H. Ikeda, T. Nishimura // Autoimmunity. – 2005. – Vol. 38. - № 5. - P. 369-75.
74.Molloy, E.J. Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone / E.J. Molloy, A.J. O'Neill, J.J. Grantham, M. SheridanPereira, J.M. Fitzpatrick, D.W. Webb, R.W. Watson // Blood. – 2003. – Vol. 102. - №
7.– P. 2653-9.
75.Morville, R. The bioavailability of natural progesterone given by mouth. Measurement of steroid concentrations in plasma, endometrium and breast tissue / R. Morville, F. Dray, J. Reynier, J. Barrat // J Gynecol Obstet Biol Reprod. – 1982. – Vol.
11.- № 3. – P. 355-63.
76.Mutter, G.L. Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia / G.L. Mutter, R.J. Zaino, J.P. Baak, R.C. Bentley, S.J. Robboy // Int. J. Gynecol. Pathol. - 2007. – Vol. 26. - № 2. - P. 103-114.
77.Mylonas, I. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR) / I. Mylonas, U. Jeschke, N. Shabani, C. Kuhn, S. Kriegel, M.S. Kupka, K. Friese // Anticancer Res. – 2005. – Vol. 25. - № 3A.
– P. 1679-86.
78.Ndiaye, K. Progesterone effects on lymphocytes may be mediated by membrane progesterone receptors / K. Ndiaye, D.H. Poole, S. Walusimbi, M.J. Cannon, K. Toyokawa, S.W. Maalouf, J. Dong, P. Thomas, J.L. Pate // J Reprod Immunol. –
2012. – Vol. 95. - № 1-2. – P. 15-26.
116
79.Orejuela, F.J. Estrogen and progesterone receptors and cyclooxygenase-
2expression in endometrial cancer, endometrial hyperplasia, and normal endometrium / F.J. Orejuela, L.M. Ramondetta, J. Smith, J. Brown, L.B. Lemos, Y. Li, L.M. Hollier // Gynecol Oncol. – 2005. – Vol. 97. - № 2. - P. 483-8.
80.O'Toole, S.A. Oestrogen regulated gene expression in normal and malignant endometrial tissue / S.A. O'Toole, E. Dunn, B.L. Sheppard, O. Sheils, J.J. O'Leary, W. Wuttke, D. Seidlova-Wuttke // Maturitas. – 2005. – Vol. 51. - № 2. – P. 187-98.
81.Pauklin, S.Progesterone inhibits activation-induced deaminase by binding to the promoter / S. Pauklin, S.K. Petersen-Mahrt // J Immunol. – 2009. – Vol.
183.- № 2. – P. 1238-44.
82.……Petrlová, B. Comparison of steroid metabolism markers in endometrium of women with endometriosis, endometrial hyperplasia and without pathological changes of endometrium / B. Petrlová, V. Hejda, Z. Ulcová-Gallová, P. Mukensnábl, Z. Rokyta // Ceska Gynekol. – 2004. – Vol. 69. - № 3. – P. 218-24.
83.Pieczyсska, B. Analysis of PTEN, estrogen receptor and progesterone receptor expression in endometrial hyperplasia using tissue microarray / B. Pieczyńska,
S. Wojtylak, A. Zawrocki, W. Biernat // Pol J Pathol. – 2011. – Vol. 62. - № 3. – P.
133-8.
84.Plataniotis, G., Castiglione M. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up / G. Plataniotis, M. Castiglione // Ann Oncol. – 2010. – Vol. 21. - № 5. - P. 67-76.
85.Reed, S.D. Incidence of endometrial hyperplasia / S.D. Reed, K.M. Newton, W.L. Clinton, M. Epplein, R. Garcia, K. Allison, L.F. Voigt, N.S. Weiss // Am J Obstet Gynecol. – 2009. Vol. 200. - № 6. – P. 678.
86.Robinson-Rechavi, M. The nuclear receptor superfamily / M. RobinsonRechavi, G. H. Escriva, V. Laudet // J Cell Sci. – 2003. – Vol. 116. – Pt. 4. – P. 585-6.
87.Samarnthai, N. Molecular Profiling of Endometrial Malignancies
[Электронный ресурс] / N. Samarnthai, K. Hall, I.T. Yeh // Obstet Gynecol Int. - 2010.
– Режим доступа: http://www.hindawi.com/journals/ogi/2010/162363/
117
88. Sánchez Anguiano, L.F. Estrogenic receptors in hyperplasia and endometrial adenocarcinoma: immunohystochemical study with image analysis / L.F.
Sánchez Anguiano, L. Puente Ledesma, E.F. Lares Bayona, R.H. Milla Villeda // Ginecol Obstet Mex. – 2007. – Vol. 75. - № 9. – P. 501-8.
89.Schmittgen, T. D. Analyzing real-time PCR data by the comparative CT method / T. D. Schmittgen, K. J. Livak // Nat Protoc. – 2008. – Vol. 3. - № 6. - P. 1101- 8.
90.Schubert, A.K. Effects of progesterone antagonists on the eosinophilic granulocytes in the rat uterus / A.K. Schubert // Ann Anat. – 1998. – Vol. 180. - № 5. P.
401-8.
91.Silverberg, S.G. Endometrial Tumours and related Lesions. WHO Classifications of Tumours, Pathology & Genetics. Tumours of the Breast and Female Genital Organs / S.G. Silverberg, G.L. Mutter, P.A. Kubik-Huch, F.A. Tavassoli - Lyon, France: IARC Press, 1994. – P. 221–232.
92.Smith, H.O. GPR30: a novel indicator of poor survival for endometrial carcinoma / H.O. Smith, K.K. Leslie, M. Singh, C.R. Qualls, C.M. Revankar, N.E. Joste, E.R. Prossnitz // Am J Obstet Gynecol. – 2007. – Vol. 196. - № 4. – P. 386.e1-9.
93.Smuc, T. Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer / T. Smuc, T.L. Rizner // Mol Cell Endocrinol. – 2009. Vol. 301. - № 1-2. – P. 74-82.
94.Snider, H. Sex hormones and modulation of immunity against leishmaniasis / H. Snider, C. Lezama-Davila, J. Alexander, A.R. Satoskar // Uroimmunomodulation. – 2009. – Vol. 16. - № 2. – P. 106-13.
95.Srijaipracharoen, S. Expression of ER, PR, and Her-2/neu in endometrial cancer: a clinicopathological study / S. Srijaipracharoen, S. Tangjitgamol, S. Tanvanich, S. Manusirivithaya, J. Khunnarong, T. Thavaramara, S. Leelahakorn, K. Pataradool // Asian Pac J Cancer Prev. – 2010. – Vol. 11. - № 1. – P. 215-20.
96.Stanczyk, F.Z. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects
118
/ F.Z. Stanczyk, J.P. Hapgood, S. Winer, D.R. Jr. Mishell //Endocr Rev. – 2013. – Vol.
34.- № 2. – P. 171-208.
97.Stoian, S.C. Endometrial carcinomas: correlation between ER, PR, Ki67 status and histopathological prognostic parameters / S.C. Stoian, C. Simionescu, C.
Mărgăritescu, A. Stepan, M. Nurciu // Rom J Morphol Embryol. – 2011. – Vol. 52. - №
2.– P. 631-6
98.Su, L. Progesterone inhibits Toll-like receptor 4-mediated innate immune response in macrophages by suppressing NF-kappaB activation and enhancing SOCS1 expression / L. Su, Y. Sun, F. Ma, P. Lü, H. Huang, J. Zhou // Immunol Lett. –
2009. - Vol. 125. - № 2. – P. 151-5.
99.Suba, Z. Carcinogenesis theory based on estrogen deficiency / Z. Suba // Orv Hetil. – 2009. – Vol. 150. - № 25. – P. 1155-66.
100.Suthipintawong, C. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma / C. Suthipintawong, C. Wejaranayang, C. Vipupinyo
//J Med Assoc Thai. – 2008. – Vol. 91. - № 12. – P. 1779-84.
101.Tait, A.S. The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease / A.S. Tait, C.L. Butts, E.M. Sternberg // J Leukoc Biol. – 2008. – Vol. 84. - № 4. – P. 924-31.
102.Tanenbaum, D.M. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains / D.M. Tanenbaum, Y. Wang, S.P. Williams, P.B. Sigler // Proc Natl Acad Sci U S A. – 1998. – Vol. 95. - № 11. – P. 5998-6003.
103.Taylor, R.N. Promegestone (R5020) and mifepristone (RU486) both function as progestational agonists of human glycodelin gene expression in isolated human epithelial cells / R.N. Taylor, J.F. Savouret, C. Vaisse, J.L. Vigne, I. Ryan, D.
Hornung, M. Seppälä, E. Milgrom // J Clin Endocrinol Metab. - 1998. – Vol. 83. - №
11.– P. 4006-12.
104.Teleman, S. An immunohistochemical study of the steroid hormone receptors in endometrial hyperplasia / S. Teleman, M. Hilgarth, N. Freudenberg, H.
119
Bettendorf, M.S. Mihailovici // Rev Med Chir Soc Med Nat Iasi. – 1999. – Vol. 103. -
№1-2. – P. 138-41.
105.Thomas, P. Steroid and G protein binding characteristics of the seatrout and human progestin membrane receptor alpha subtypes and their evolutionary origins / P. Thomas, Y. Pang, J. Dong, P. Groenen, J. Kelder, J. de Vlieg, Y. Zhu, C. Tubbs // Endocrinology. – 2007. – Vol. 148. - № 2. - P.705-18.
106.Vandenput, I. Evolution in endometrial cancer: evidence from an immunohistochemical study / I. Vandenput, J. Trovik, K. Leunen, E. Wik, I. Stefansson, L. Akslen, P. Moerman, I. Vergote, H. Salvesen, F. Amant // Int J Gynecol Cancer. –
2011. – Vol. 21. - № 2. – P. 316-22.
107. Vrachnis, N. Immune aspects and myometrial actions of progesterone and CRH in labor [электронный ресурс] / N. Vrachnis, F.M. Malamas, S. Sifakis, P. Tsikouras, Z. Iliodromiti // Clin Dev Immunol. - 2012. – Vol. 2012. – Режим доступа: http://dx.doi.org/10.1155/2012/937618
108.Witkiewicz, A.K. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins / A.K. Witkiewicz, T. McConnell, M. Potoczek, R.V. Emmons, R.J. Kurman // Hum Pathol. – 2010. – Vol. 41. - № 1. – P. 26-32.
109.Wolfson, M.L. Progesterone reverts LPS-reduced FAAH activity in murine peripheral blood mononuclear cells by a receptor-mediated fashion / M.L.
Wolfson, J. Aisemberg, A.I. Salazar, A.P. Domínguez Rubio, C.A. Vercelli, A.M. Franchi // Mol Cell Endocrinol. – 2013. - Vol. 381. - № 1-2. – P. 97-105.
110. Xu, Y. Immunosuppressive effect of progesterone on dendritic cells in mice / Y. Xu, H. He, C. Li, Y. Shi, Q. Wang, W. Li, W. Song // J Reprod Immunol. – 2011. – Vol. 91. - № 1-2. – P.17-23.
111. Yao, Y.Y. Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma / Y.Y. Yao, W.Z. Xu, Y. Wang, D.H. Shen, J.L. Wang, L.H.Wei // Beijing Da Xue Xue Bao. – 2011. – Vol. 43. - № 5. – P. 743-8.